A detailed history of Gardner Lewis Asset Management L P transactions in Eli Lilly & CO stock. As of the latest transaction made, Gardner Lewis Asset Management L P holds 2,450 shares of LLY stock, worth $1.92 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
2,450
Previous 2,450 -0.0%
Holding current value
$1.92 Million
Previous $2.22 Million 2.16%
% of portfolio
0.61%
Previous 0.65%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $1.45 Million - $1.94 Million
2,450 New
2,450 $1.91 Million
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $1.4 Million - $1.74 Million
-5,966 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $1.34 Million - $1.66 Million
5,966 New
5,966 $1.65 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $743B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gardner Lewis Asset Management L P Portfolio

Follow Gardner Lewis Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gardner Lewis Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Gardner Lewis Asset Management L P with notifications on news.